Core Scientific (CORZ) Asset Writedowns and Impairment (2022 - 2026)

Core Scientific has disclosed Asset Writedowns and Impairment across 4 years of filings, most recently posting $266.5 million for Q1 2026.

• Asset Writedowns and Impairment for Q1 2026 came in at $266.5 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $277.8 million (changed N/A YoY), and the FY2025 annual result was $11.4 million, changed N/A from the prior year.
• Asset Writedowns and Impairment came in at $266.5 million for Q1 2026 at Core Scientific, up from $11.4 million in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $790.8 million in Q2 2022 to a low of -$784.8 million in Q3 2022.
• The 4-year median for Asset Writedowns and Impairment is $11.4 million (2025), against an average of $41.0 million.
• Peak annual rise in Asset Writedowns and Impairment reached 111.68% in 2025, while the deepest fall reached 111.68% in 2025.
• Core Scientific's Asset Writedowns and Impairment stood at $3.1 million in 2022, then plunged by 3277.43% to -$97.3 million in 2024, then jumped by 111.68% to $11.4 million in 2025, then soared by 2246.05% to $266.5 million in 2026.
• The last three Asset Writedowns and Impairment figures came in at $266.5 million (Q1 2026), $11.4 million (Q4 2025), and -$97.3 million (Q4 2024), per Business Quant data.